Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION USP

Last updated on 2017-12-22 History
Report ID 14737
Drug Identification Number 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10
Common or Proper name HYDROMORPHONE HYDROCHLORIDE
Company Name PFIZER CANADA ULC
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10X5ML
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-06-24
Actual start date
Estimated end date
Actual end date 2017-12-21
Shortage status Avoided shortage
Updated date 2017-12-22
Company comments Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-12-22 French Compare
v3 2017-12-22 English Compare
v2 2017-07-05 French Compare
v1 2017-07-05 English Compare